Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations M Laamarti, T Alouane, S Kartti, MW Chemao-Elfihri, M Hakmi, ... PloS one 15 (11), e0240345, 2020 | 101 | 2020 |
Genomic diversity and hotspot mutations in 30,983 SARS-CoV-2 genomes: moving toward a universal vaccine for the “confined virus”? T Alouane, M Laamarti, A Essabbar, M Hakmi, EM Bouricha, ... Pathogens 9 (10), 829, 2020 | 73* | 2020 |
Targeting the GRP78-dependant SARS-CoV-2 cell entry by peptides and small molecules L Allam, F Ghrifi, H Mohammed, N El Hafidi, R El Jaoudi, J El Harti, ... Bioinformatics and Biology Insights 14, 1177932220965505, 2020 | 66 | 2020 |
Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis M Hakmi, EM Bouricha, I Kandoussi, J El Harti, A Ibrahimi Bioinformation 16 (4), 301, 2020 | 50 | 2020 |
In silico analysis of ACE2 orthologues to predict animal host range with high susceptibility to SARS-CoV-2 EM Bouricha, M Hakmi, J Akachar, L Belyamani, A Ibrahimi 3 Biotech 10 (11), 483, 2020 | 16 | 2020 |
In silico exploration of small-molecule α-helix mimetics as inhibitors of SARS-COV-2 attachment to ACE2 M Hakmi, ELM Bouricha, J Akachar, B Lmimouni, J El Harti, L Belyamani, ... Journal of Biomolecular Structure and Dynamics 40 (4), 1546-1557, 2022 | 10 | 2022 |
Anthraquinones: A promising multi-target therapeutic scaffold to treat covid-19 S El Mazouri, T Aanniz, J Touhtouh, I Kandoussi, M Hakmi, L Belyamani, ... International Journal of Applied Biology and Pharmaceutical Technology 12 (1 …, 2021 | 10 | 2021 |
Identifying epitopes for cluster of differentiation and design of new peptides inhibitors against human SARS-CoV-2 spike RBD by an in-silico approach J Akachar, EM Bouricha, M Hakmi, L Belyamani, R El Jaoudi, A Ibrahimi Heliyon 6 (12), 2020 | 7 | 2020 |
In-silico identification of potential inhibitors targeting the DNA binding domain of estrogen receptor α for the treatment of hormone therapy-resistant breast cancer EM Bouricha, M Hakmi, J Akachar, F Zouaidia, A Ibrahimi Journal of Biomolecular Structure and Dynamics 40 (11), 5203-5210, 2022 | 6 | 2022 |
IDbSV: an open-access repository for monitoring sars-cov-2 variations and evolution A Essabbar, S Kartti, T Alouane, M Hakmi, L Belyamani, A Ibrahimi Frontiers in Medicine 8, 765249, 2021 | 6 | 2021 |
Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations. bioRxiv 2020.05. 03.074567 M Laamarti, T Alouane, S Kartti, MW Chemao-Elfihri, M Hakmi, ... DOI 10 (2020.05), 03.074567, 2020 | 5 | 2020 |
Genomic analysis of Paenibacillus sp. MDMC362 from the Merzouga desert leads to the identification of a potentially thermostable catalase MW Chemao-Elfihri, M Hakmi, A Essabbar, A Manni, M Laamarti, S Kartti, ... Antonie van Leeuwenhoek 116 (1), 21-38, 2023 | 2 | 2023 |
Mechanistic evidence from classical molecular dynamics and metadynamics revealed the mechanism of resistance to 4-hydroxy tamoxifen in estrogen receptor alpha Y537S mutant EM Bouricha, M Hakmi, S Kartti, F Zouaidia, A Ibrahimi Molecular Simulation 48 (16), 1456-1463, 2022 | 2 | 2022 |
In Silico Identification of Natural Food Compounds as Potential Quorum-Sensing Inhibitors Targeting the LasR Receptor of Pseudomonas aeruginosa M Magri, EM Bouricha, M Hakmi, REL Jaoudi, L Belyamani, A Ibrahimi Bioinformatics and Biology Insights 17, 11779322231212755, 2023 | 1 | 2023 |
In silico analyses of all STAT3 missense variants leading to explore divergent AD-HIES clinical phenotypes M Mansouri, G El Haddoumi, H Bendani, N Boumajdi, M Hakmi, H Abbou, ... Evolutionary Bioinformatics 19, 11769343231169374, 2023 | 1 | 2023 |
Computational modeling and druggability assessment of Aggregatibacter actinomycetemcomitans leukotoxin M Hakmi, EM Bouricha, J El Harti, S Amzazi, L Belyamani, JE Khanfri, ... Computer Methods and Programs in Biomedicine 222, 106952, 2022 | 1 | 2022 |